November 20, 2018
Strongbridge Biopharma plc Announces Presentation of New Data Comparing the In Vitro Effects of Levoketoconazole, the Active Ingredient in RECORLEV™, and Ketoconazole on Human Cortisol Production
Media
November 19, 2018
BONESUPPORT™ – POSITIVE RESULTS FROM THE CERTiFy STUDY COMPARING CERAMENT®|BONE VOID FILLER WITH AUTOGRAFT
November 19, 2018
Q3 2018 General Market Overview
November 16, 2018
Targovax to present at NeoAg Summit 2018
November 15, 2018
Camel-IDS completes EUR 37m Series A financing to develop cancer-targeted radiopharmaceuticals
November 13, 2018
Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update
November 08, 2018
InCarda Therapeutics Provides Corporate Update Highlighting Fundraising and Clinical Development Milestones
November 08, 2018
Interim report July-September 2018
November 07, 2018
Modus Therapeutics announces FDA Acceptance of Sevuparin IND for treatment of sickle cell disease
November 07, 2018
MIPS INTERIM REPORT JANUARY – SEPTEMBER 2018